- ASSOCIATE PROFESSOR Medicine, Rheumatology
American Board of Internal Medicine
BM, Royal Free Hospital Sch of Medicine
Residency, Internal Medicine
Oregon Health Sciences University
* Yale University School of Medicine *
Dr. Ali is a graduate of the Royal Free Hospital School of Medicine in London. After 2 years of postgraduate training in the UK he moved to the US and completed Internal Medicine training at OHSU in Portland, Oregon. He then trained in Rheumatology at Yale University and is board certified in both Rheumatology and Internal Medicine. He is the current Vice Chair of Faculty Affairs in the Department of Medicine. Dr. Ali was in practice in Providence, Rhode Island for 9 years where he was an Assistant Clinical Professor of Medicine at Brown University. He received many awards including the prestigious Beckwith Family award for outstanding teaching.
He has published many articles, book chapters, and has lectured widely on Rheumatoid arthritis, Osteoporosis, Gout, SLE, Osteoarthritis and the development and study of Novel Biologic therapeutics.
Top Doctors in New York
2007 - 2008
Best Doctors in Rhode Island
2006 - 2006
Beckwith Family Award for outstanding teaching
2004 - 2004
Teaching Recognition Award
2001 - 2001
Dr Ali is currently PI on several trials investigating new treatments for SLE and RA. He is also developing a patient centric app to predict flares in RA that should improve care and outcome.
Embrace Study: phase 3/4, multi-center, randomized, double-blind, placebo-controlled,52-week study to evaluate the efficacy and safety of belimumab (HGS1006) in adult subjects of black race with SLE
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthritis Despite Anti-TNF Therapy
Hyaluronan Injections for Osteoarthritis of the Knee [review]. Med Lett Drugs Ther.; 40(1030).
Refractory Scleritis Associated with Hepatitis C and Cyroglobulinemia. J Clinical Rheumatology 1999 December;.
Acute pseudogout following intr-articular injection of high molecular weight hyaluronic acid. Am J Med 1999 December ; 107(6): 641-642.
Infliximab induced SLE. Annals Internal Medicine 2002 October; 137(7): 625-626.
Always trust your gut feeling. The Lancet 2005 March; 365(9465): 1201.
Ali Y, Perlman E. Successful treatment of refractory sarcoid associated uveitis with Inflixmab. Annals of Internal Medicine 2004 June; 140(3465): no.11 W-48.
Ali . Self Assessment Questions in Rheumatology . Humana Press;.
Evaluation of the patient with Musculoskeletal symptoms. In: Hand Surgery. LWW Book;prettyprintp625-628.
Gout and Pseudogout: Primary Care for Women. Lippincott Williams & Wilkins 2nd Edition;prettyprintp633-636.
Aaron RK, Voisinet A, Racine J, Ali Y, Feller ER. Corticosteroid-associated avascular necrosis: dose relationships and early diagnosis. Annals of the New York Academy of Sciences 2011 Dec; 1240.
Bartov JB, Ali Y. Successful use of the interleukin 1 antagonist, anakinra, in a patient with gout, chronic kidney disease, and aplastic anemia. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2013 Dec; 19(8).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Ali did not report having any of the following types of financial relationships with industry during 2014 and/or 2015: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Annenberg Building Floor 21 Room 56
1468 Madison Avenue
New York, NY 10029
Annenberg Building Floor 5 Room 02F
1468 Madison Avenue
New York, NY 10029
Mount Sinai Faculty Practice Associates
5 East 98th Street
New York, NY 10029
- Monday 9:00am - 5:00pm
- Tuesday 9:00am - 5:00pm
- Wednesday 9:00am - 5:00pm
- Thursday 9:00am - 5:00pm
- Friday 9:00am - 5:00pm
- 1199 National Benefit Fund
- Aetna Indeminty
- Aetna U.S. Healthcare
- Aetna U.S. Healthcare - HMO
- Blue Choice
- Blue Choice - HMO
- Blue Cross/ Blue Shield
- Blue Cross/ Blue Shield - HMO
- Blue Shield Wrap Around Plus
- CIGNA - Indemnity
- CIGNA Healthcare HMO
- Empire Blue Cross/ Blue Shield - HMO
- Empire Blue Cross/Blue Shield
- Empire Plan/UHC
- First Health
- Group Health Insurance (GHI) - HMO
- Group Health Insurance, Inc.
- HIP of New Jersey
- HIP of New Jersey - HMO
- Health Insurance Plan (HIP)
- Health Insurance Plan (HIP) - HMO
- HealthSource NY/NJ
- Island Group
- MultiPlan, Inc.
- Oxford Health Plans
- Prem Preferred Care/Beechstreet
- Prudential Healthcare: a member company of Aetna
- United Healthcare
- Master Card
- American Express
- Personal Check